Biomarker . | Plasma levels in ADHF . | Independent prognostic information? . | Levels altered with therapy? . | Plasma levels in CHF . | Independent prognostic information? . | Levels altered with therapy? . |
---|---|---|---|---|---|---|
MR-proANP | ↑ | Yes | U | ↑ | Yes | U |
MR-proADM | U | U | U | ↑ | Yes | U |
copeptin | ↑ | Yes | U | ↑ | Yes | U |
Apelin | ↔ | No | No | ↓ | U | Yes |
Urocortin | U | U | U | ↑ | U | U |
CgA | ↑ | Yes | U | ↑ | Yes | No |
CoQ10 | U | U | U | ↓ | Yes | U |
Adiponectin | ↑ | Yes | U | ↑ | Yes | U |
H-FABP | U | U | U | ↑ | Yes | Yes |
MLC-1 | U | U | U | ↑ | Yes | U |
Osteopontin | U | U | U | ↑ | Yes | U |
GDF-15 | U | U | U | ↑ | Yes | U |
Pentraxin-3 | U | U | U | ↑ | Yes | U |
Secretory sphingomyelinase | U | U | U | ↑ | Yes | U |
CT-1 | U | U | U | ↑ | Yes | U |
Gal-3 | ↑ | Yes | U | ↑ | U | No |
ST2 | ↑ | Yes | U | ↑ | Yes | U |
Cystatin C | ↑ | Yes | U | ↑ | Yes | U |
SP-B | ↑ | U | Yes | ↑ | U | Yes |
Biomarker . | Plasma levels in ADHF . | Independent prognostic information? . | Levels altered with therapy? . | Plasma levels in CHF . | Independent prognostic information? . | Levels altered with therapy? . |
---|---|---|---|---|---|---|
MR-proANP | ↑ | Yes | U | ↑ | Yes | U |
MR-proADM | U | U | U | ↑ | Yes | U |
copeptin | ↑ | Yes | U | ↑ | Yes | U |
Apelin | ↔ | No | No | ↓ | U | Yes |
Urocortin | U | U | U | ↑ | U | U |
CgA | ↑ | Yes | U | ↑ | Yes | No |
CoQ10 | U | U | U | ↓ | Yes | U |
Adiponectin | ↑ | Yes | U | ↑ | Yes | U |
H-FABP | U | U | U | ↑ | Yes | Yes |
MLC-1 | U | U | U | ↑ | Yes | U |
Osteopontin | U | U | U | ↑ | Yes | U |
GDF-15 | U | U | U | ↑ | Yes | U |
Pentraxin-3 | U | U | U | ↑ | Yes | U |
Secretory sphingomyelinase | U | U | U | ↑ | Yes | U |
CT-1 | U | U | U | ↑ | Yes | U |
Gal-3 | ↑ | Yes | U | ↑ | U | No |
ST2 | ↑ | Yes | U | ↑ | Yes | U |
Cystatin C | ↑ | Yes | U | ↑ | Yes | U |
SP-B | ↑ | U | Yes | ↑ | U | Yes |
↑: raised; ↓: reduced; ↔: no change; ADHF; acutely decompensated heart failure; CHF, congestive heart failure; U, unknown.
Adapted from Dalzel JR et al. Biomark Med 2009;3(5):483–93.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.